Company / R&D Expense
PetVivo Holdings, Inc. R&D Expense History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$1.6M
FY2024
5-year range
$474.9K / $1.6M
FY2020-FY2024
Trend
+13.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has increased for 5 consecutive years, from $12,672 in FY2019 to $2M in FY2024.
Based on SEC 10-K filings.
$2M in FY2024 with a 5-year CAGR of +162.6%.
Improved from $996,358 to $2M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +49.4%
- 5-Year CAGR
- +162.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- PetVivo Holdings, Inc.'s r&d expense has grown for 5 consecutive years.
- 5-year CAGR of +162.6%, indicating consistent growth.
- In FY2024, r&d expense increased 13.5% year-over-year.
- Lowest r&d expense in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -7.83 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $1.6M | +13.5% |
| FY2023 | $1.4M | +40.0% |
| FY2022 | $996.4K | +109.8% |
| FY2021 | $474.9K | +383.4% |
| FY2020 | $98.2K | +675.2% |
| FY2019 | $12.7K | -93.7% |
| FY2018 | $201.0K | +69.0% |
| FY2017 | $118.9K | -29.5% |
| FY2016 | $168.6K | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026